We are excited that Nordic Blue with their experience and success in the field of wound care continue to believe and are willing to support Regenics in the further development of Collex®. Their investment and participation at the board level have been of great value this past year and we look forward to continuing our successful collaboration

We continue to see tremendous potential in Regenics and its wound care products. Collex® represents an effective and sustainable approach to wound care, and we are proud to continue supporting its development. With Regenics’ strong scientific foundation and clear clinical focus, we believe the company is well-positioned to make a meaningful impact in the wound care market. Our increased investment reflects our confidence in the team and in the broader vision of building value through marine-based biotech innovation

We believe Jostein is an excellent choice for the CEO role and that he will be a strong addition to the Regenics team

His experience and knowledge in wound healing product development will be essential to the successful development of Collex®